Abstract

Introduction/Objective: Introducing 2-dose schedules of MMR vaccination in many European countries has reduced the incidence of mumps by 97-99%. However, despite the decline of incidence in all parts of the world, outbreaks of mumps are occurring. The objective of this descriptive study was to analyze the occurrence of mumps and coverage of the first dose of MMR vaccine in Montenegro during the period from 2009 to 2018. Methods: Data on the number of new patients, taken from the annual reports of the Institute of Public Health of Montenegro on the movement of infectious diseases, were used to analyze the incidence of mumps in the territory of Montenegro from 2009 to 2018, and to estimate the coverage of the first dose of MMR vaccine data were taken from annual immunization reports in Montenegro and from the electronic immunization registry. Results: In Montenegro, between 2009 and 2018, a total of 256 cases of mumps were registered, of which 63% were males and there were no fatalities. The standardized incidence rate of mumps (standardized by world population) was higher for men than women, and ranged from 0 (2018) to 12.4 per 100,000 men (2012) and from 0.2 (2015-2018) to 7.6 per 100,000 women (2012). In both sexes and in the general population, the lowest average values of age-specific incidence rates were observed in the ages up to 4 years of age and in the over 30s. The largest number of cases of mumps was registered in April and July. The lowest coverage with the first dose of MMR vaccine of only 42.1% was recorded in 2018. Conclusion: It is necessary to increase and maintain the the level of MMR vaccine coverage among all persons who have to be vaccinated. It is also necessary to expand educational work on health-care among the general population, especially among parents, in order to advance the knowledge about the importance of vaccination and the potential dangers that vaccine-preventable diseases carry with them, in order to restore the high level of trust that the anti-vaccine lobby has eroded.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call